Ikaria makes Tasos Konidaris CFO
This article was originally published in Scrip
Critical care company Ikaria, which is developing therapies for critically ill patients in hospital and ICU settings, has appointed Tasos Konidaris senior vice-president and chief financial officer. He succeeds Craig Tooman who left the company early in 2011. Mr Konidaris most recently served as senior vice-president and CFO at Dun & Bradstreet since 2007. Before that, he was group vice-president at Schering Plough.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.